Molecule Pages / Capsules
Rabeprazole 20 Mg & Itopride Hcl 150 Mg Sr Capsules
PRODUCT DESCRIPTION RABEGA-ISR CAPSULE is a combination formulation containing: Rabeprazole Sodium 20 mg (Enteric Coated Pellets) ? Proton Pump Inhibitor (PPI) that reduces gastric acid secretion Itopride HCl 150 mg (Sustained Release) ? Prokinetic agent that improves gastric motility This combination provides comprehensive relief from gastroesophageal reflux disease (GERD), acid reflux, heartburn, bloating, and delayed gastric emptying.
Pricing is not displayed on this page. Use the RFQ form to discuss commercial requirements.
Composition: Rabeprazole 20 Mg & Itopride Hcl 150 Mg Sr
Dosage Form: Capsules
Indications: RABEGA-ISR Capsules combine Rabeprazole Sodium 20 mg (enteric-coated) and Itopride HCl 150 mg (SR) for effective management of acid reflux, GERD, and delayed gastric emptying. Trusted gastrointestinal support formulation.
Packaging: 10x10 ALU-ALU
Storage: Store in a cool, dry place below 25C.
Category: Capsules
Matching Products
Related Molecule Pages
Acebrophylline 100mg Capsules
Capsules | 2 products
Aceclofenac 200mg, Rabeprazole 20mg (sr) Capsules
Capsules | 2 products
Alpha Galactosidase, Alpha Amylase, Lipase, Protease, Lactase Capsules
Capsules | 1 product
Amoxicillin 250mg Capsules
Capsules | 4 products
Amoxicillin 500mg + Lactic Acid Bacillus 60m Capsules
Capsules | 1 product
Amoxicillin 500mg Capsules
Capsules | 4 products
Amoxicillin 500mg, Lactic Acid Bacillus 60 Million Spores Capsules
Capsules | 1 product
Amoxycillin 250 Mg, Cloxacillin 250 Mg Capsules
Capsules | 2 products